Sign in

CIK 0000822370

  • Non-accelerated filer
  • Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870419387
Phone
+1 310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Grant or award Director acquired 18,000 shares (grant or award)
  2. 4 Grant or award Director acquired 12,000 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 5,000 shares at $3.34 ($16,684)
  7. 4 Open-market buy Director bought 5,000 shares at $3.65 ($18,242)
  8. 4 Open-market buy Director bought 5,000 shares at $4.00 ($19,996)
  9. 4 Open-market buy Director bought 10,000 shares at an average $4.25 ($42,493)
  10. 4 Open-market buy Director bought 10,000 shares at an average $4.47 ($44,695)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 25,000 shares (grant or award)
  14. 4 Open-market buy Director bought 9,878 shares at $6.46 ($63,843)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy 10% owner bought 160,000 shares at $6.25 ($1,000,000)
  18. 4 Grant or award Director acquired 40,000 shares (grant or award)
  19. 4 Grant or award Director acquired 5,000 shares (grant or award)
  20. 4 Grant or award Director acquired 32,000 shares (grant or award)

Page 14 of 25 · 488 filings